MCGLYNN MARGARET G
Insider CIK 1215126 · NVAX Director · FOLD Director · APD Director · VRTX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NVAX NOVAVAX INC | M Exercise deriv | 2026-06-20 | 2026-06-23 | 18,880 | — | $0 | 0 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2026-06-20 | 2026-06-23 | 18,880 | — | $0 | 44,468 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2026-06-18 | 2026-06-23 | 21,270 | — | $0 | 21,270 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2026-06-18 | 2026-06-23 | 14,180 | — | $0 | 14,180 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | D To issuer deriv | 2026-04-27 | 2026-04-27 | 36,111 | — | $0 | 0 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | D To issuer deriv | 2026-04-27 | 2026-04-27 | 42,467 | — | $0 | 0 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | D To issuer deriv | 2026-04-27 | 2026-04-27 | 16,236 | — | $0 | 0 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | D To issuer deriv | 2026-04-27 | 2026-04-27 | 45,423 | — | $0 | 0 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | D To issuer deriv | 2026-04-27 | 2026-04-27 | 30,474 | — | $0 | 0 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | D To issuer deriv | 2026-04-27 | 2026-04-27 | 18,574 | — | $0 | 0 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | D To issuer deriv | 2026-04-27 | 2026-04-27 | 74,872 | — | $0 | 0 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | D To issuer deriv | 2026-04-27 | 2026-04-27 | 20,000 | — | $0 | 0 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | D To issuer deriv | 2026-04-27 | 2026-04-27 | 19,473 | — | $0 | 0 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | D To issuer | 2026-04-27 | 2026-04-27 | 94,631 | $14.50 | $1.37M | 0 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2025-06-20 | 2025-06-24 | 18,884 | — | $0 | 18,884 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2025-06-20 | 2025-06-24 | 28,326 | $6.42 | $181.9K | 28,326 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2025-06-12 | 2025-06-16 | 10,420 | — | $0 | 0 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2025-06-12 | 2025-06-16 | 10,420 | — | $0 | 25,588 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | A Award deriv | 2025-06-05 | 2025-06-06 | 74,872 | — | $0 | 74,872 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | A Award | 2025-06-05 | 2025-06-06 | 20,414 | — | $0 | 91,550 | SEC↗ |
| NVAX NOVAVAX INC | A Award | 2024-12-31 | 2025-02-05 | 1,178 | $8.61 | $10.1K | 15,168 | SEC↗ |
| NVAX NOVAVAX INC | A Award | 2024-09-30 | 2025-02-05 | 778 | $12.77 | $9.9K | 13,990 | SEC↗ |
| NVAX NOVAVAX INC | A Award | 2024-06-30 | 2025-02-05 | 713 | $13.93 | $9.9K | 13,212 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2024-06-12 | 2024-06-14 | 10,420 | — | $0 | 10,420 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2024-06-12 | 2024-06-14 | 15,630 | $15.86 | $247.9K | 15,630 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2024-06-12 | 2024-06-14 | 6,670 | — | $0 | 0 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2024-06-12 | 2024-06-14 | 6,670 | — | $0 | 10,470 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | A Award deriv | 2024-06-06 | 2024-06-07 | 42,467 | — | $0 | 42,467 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | A Award | 2024-06-06 | 2024-06-07 | 11,847 | — | $0 | 71,136 | SEC↗ |
| NVAX NOVAVAX INC | A Award | 2024-03-31 | 2025-02-05 | 2,029 | $4.90 | $9.9K | 5,829 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | M Exercise deriv | 2024-03-05 | 2024-03-06 | 7,500 | — | $0 | 0 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | S Sale | 2024-03-05 | 2024-03-06 | 7,500 | $13.40 | $100.5K | 59,289 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | M Exercise | 2024-03-05 | 2024-03-06 | 7,500 | $2.80 | $21.0K | 66,789 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | M Exercise deriv | 2024-03-04 | 2024-03-06 | 7,500 | — | $0 | 7,500 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | M Exercise | 2024-03-04 | 2024-03-06 | 7,500 | $2.80 | $21.0K | 66,789 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | S Sale | 2024-03-04 | 2024-03-06 | 7,500 | $13.29 | $99.7K | 59,289 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2023-06-12 | 2023-06-13 | 6,670 | — | $0 | 6,670 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2023-06-12 | 2023-06-13 | 7,710 | — | $0 | 7,710 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2023-06-10 | 2023-06-13 | 3,100 | — | $0 | 0 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2023-06-10 | 2023-06-13 | 3,100 | — | $0 | 3,800 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | A Award deriv | 2023-06-08 | 2023-06-12 | 30,474 | — | $0 | 30,474 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | A Award | 2023-06-08 | 2023-06-12 | 8,584 | — | $0 | 59,289 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2023-05-01 | 2023-05-03 | 3,481 | — | $0 | 3,481 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | M Exercise deriv | 2023-01-13 | 2023-01-17 | 15,000 | — | $0 | 0 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | S Sale | 2023-01-13 | 2023-01-17 | 15,000 | $13.03 | $195.4K | 50,705 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | M Exercise | 2023-01-13 | 2023-01-17 | 15,000 | $3.32 | $49.8K | 65,705 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2022-06-17 | 2022-06-21 | 700 | — | $0 | 0 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2022-06-17 | 2022-06-21 | 700 | — | $0 | 700 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2022-06-10 | 2022-06-14 | 3,100 | — | $0 | 3,100 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2022-06-10 | 2022-06-14 | 4,600 | — | $0 | 4,600 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | A Award deriv | 2022-06-09 | 2022-06-10 | 45,423 | — | $0 | 45,423 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | A Award | 2022-06-09 | 2022-06-10 | 12,671 | — | $0 | 50,705 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | D To issuer deriv | 2022-05-02 | 2022-05-04 | 15,000 | — | $0 | 0 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | M Exercise | 2022-05-02 | 2022-05-04 | 15,000 | $4.79 | $71.8K | 53,034 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | S Sale | 2022-05-02 | 2022-05-04 | 15,000 | $6.99 | $104.8K | 38,034 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2022-05-01 | 2022-05-03 | 921 | — | $0 | 5,609 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2022-05-01 | 2022-05-03 | 4,462 | — | $0 | 4,462 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | D To issuer | 2022-05-01 | 2022-05-03 | 921 | — | $0 | 178 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2022-04-08 | 2022-04-12 | 5,000 | — | $0 | 5,000 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2022-04-08 | 2022-04-12 | 5,000 | $127.54 | $637.7K | 6,099 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2022-04-08 | 2022-04-12 | 100 | $281.49 | $28.1K | 1,099 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2022-04-08 | 2022-04-12 | 4,900 | $280.19 | $1.37M | 1,199 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2022-03-31 | 2022-04-04 | 5,000 | $127.54 | $637.7K | 10,000 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2022-03-31 | 2022-04-04 | 1,019 | $261.28 | $266.2K | 5,080 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2022-03-31 | 2022-04-04 | 2,970 | $262.37 | $779.2K | 2,110 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2022-03-31 | 2022-04-04 | 1,011 | $262.97 | $265.9K | 1,099 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2022-03-31 | 2022-04-04 | 5,000 | $127.54 | $637.7K | 6,099 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2022-01-28 | 2022-02-01 | 5,000 | $127.54 | $637.7K | 15,000 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2022-01-28 | 2022-02-01 | 1,901 | $240.53 | $457.2K | 4,198 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2022-01-28 | 2022-02-01 | 5,000 | $127.54 | $637.7K | 6,099 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2022-01-28 | 2022-02-01 | 2,087 | $242.78 | $506.7K | 1,311 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2022-01-28 | 2022-02-01 | 212 | $243.24 | $51.6K | 1,099 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2022-01-28 | 2022-02-01 | 800 | $241.83 | $193.5K | 3,398 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2021-06-17 | 2021-06-22 | 700 | — | $0 | 700 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2021-06-17 | 2021-06-22 | 1,300 | — | $0 | 1,300 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | A Award deriv | 2021-06-10 | 2021-06-14 | 36,111 | — | $0 | 36,111 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | A Award | 2021-06-10 | 2021-06-14 | 10,115 | — | $0 | 38,034 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2021-06-01 | 2021-06-03 | 699 | — | $0 | 4,688 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | D To issuer | 2021-06-01 | 2021-06-03 | 699 | — | $0 | 1,099 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | M Exercise deriv | 2021-05-03 | 2021-05-05 | 10,000 | — | $0 | 0 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | S Sale | 2021-05-03 | 2021-05-05 | 10,000 | $10.27 | $102.7K | 27,919 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | M Exercise | 2021-05-03 | 2021-05-05 | 10,000 | $7.51 | $75.1K | 37,919 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2021-05-01 | 2021-05-04 | 3,034 | — | $0 | 3,034 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2021-05-01 | 2021-05-04 | 921 | — | $0 | 1,798 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2020-12-07 | 2020-12-09 | 7,700 | — | $0 | 7,700 | SEC↗ |
| APD AIR PRODUCTS & CHEMICALS I | A Award deriv | 2020-09-30 | 2020-10-01 | 194 | $293.86 | $57.1K | 42,814 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | G Gift | 2020-08-25 | 2020-08-26 | 3,707 | — | $0 | 877 | SEC↗ |
| APD AIR PRODUCTS & CHEMICALS I | A Award deriv | 2020-06-30 | 2020-07-02 | 238 | $238.61 | $56.8K | 42,619 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | A Award deriv | 2020-06-04 | 2020-06-08 | 18,574 | — | $0 | 18,574 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | A Award | 2020-06-04 | 2020-06-08 | 5,855 | — | $0 | 27,919 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2020-06-01 | 2020-06-03 | 2,264 | — | $0 | 2,264 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2020-06-01 | 2020-06-03 | 699 | — | $0 | 4,584 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | M Exercise deriv | 2020-04-17 | 2020-04-20 | 10,000 | — | $0 | 0 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | S Sale | 2020-04-17 | 2020-04-20 | 10,000 | $11.00 | $110.0K | 22,064 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | M Exercise | 2020-04-17 | 2020-04-20 | 10,000 | $2.81 | $28.1K | 32,064 | SEC↗ |
| APD AIR PRODUCTS & CHEMICALS I | A Award deriv | 2020-03-31 | 2020-04-02 | 237 | $206.53 | $48.9K | 42,381 | SEC↗ |
| APD AIR PRODUCTS & CHEMICALS I | A Award deriv | 2020-01-23 | 2020-01-24 | 630 | $238.04 | $150.0K | 42,145 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | M Exercise deriv | 2020-01-09 | 2020-01-10 | 20,000 | — | $0 | 0 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | M Exercise | 2020-01-09 | 2020-01-10 | 20,000 | $3.32 | $66.4K | 42,064 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | S Sale | 2020-01-09 | 2020-01-10 | 20,000 | $10.00 | $200.0K | 22,064 | SEC↗ |
| APD AIR PRODUCTS & CHEMICALS I | A Award deriv | 2019-12-31 | 2020-01-03 | 204 | $235.33 | $47.9K | 41,514 | SEC↗ |
| APD AIR PRODUCTS & CHEMICALS I | A Award deriv | 2019-11-26 | 2019-11-27 | 3,973 | — | $0 | 41,311 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | G Gift | 2019-11-18 | 2019-11-20 | 239 | — | $0 | 3,885 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2019-10-22 | 2019-10-24 | 20,000 | — | $0 | 0 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2019-10-22 | 2019-10-24 | 20,000 | $190.00 | $3.80M | 4,124 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2019-10-22 | 2019-10-24 | 20,000 | $72.14 | $1.44M | 24,124 | SEC↗ |
| APD AIR PRODUCTS & CHEMICALS I | A Award deriv | 2019-09-30 | 2019-10-02 | 199 | $221.86 | $44.3K | 37,246 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2019-08-13 | 2019-08-15 | 10,000 | — | $0 | 0 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2019-08-13 | 2019-08-15 | 10,000 | $81.54 | $815.4K | 14,124 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2019-08-13 | 2019-08-15 | 10,000 | $185.00 | $1.85M | 4,124 | SEC↗ |
| APD AIR PRODUCTS & CHEMICALS I | A Award deriv | 2019-07-01 | 2019-07-02 | 195 | $226.37 | $44.0K | 37,046 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | A Award deriv | 2019-06-27 | 2019-07-01 | 19,473 | — | $0 | 19,473 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | A Award | 2019-06-27 | 2019-07-01 | 6,250 | — | $0 | 22,064 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2019-06-01 | 2019-06-04 | 6,659 | — | $0 | 6,659 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2019-06-01 | 2019-06-04 | 1,801 | — | $0 | 3,989 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | D To issuer | 2019-06-01 | 2019-06-04 | 1,801 | — | $0 | 4,124 | SEC↗ |
| APD AIR PRODUCTS & CHEMICALS I | A Award deriv | 2019-04-01 | 2019-04-02 | 217 | $186.51 | $40.5K | 36,852 | SEC↗ |
| APD AIR PRODUCTS & CHEMICALS I | A Award deriv | 2019-01-24 | 2019-01-25 | 952 | $157.71 | $150.1K | 36,634 | SEC↗ |
| APD AIR PRODUCTS & CHEMICALS I | A Award deriv | 2018-12-31 | 2019-01-02 | 257 | $156.92 | $40.2K | 35,682 | SEC↗ |
| APD AIR PRODUCTS & CHEMICALS I | A Award deriv | 2018-09-30 | 2018-10-01 | 236 | $167.80 | $39.7K | 35,426 | SEC↗ |
| APD AIR PRODUCTS & CHEMICALS I | A Award deriv | 2018-06-30 | 2018-07-02 | 254 | $155.16 | $39.4K | 35,190 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | A Award deriv | 2018-06-07 | 2018-06-11 | 8,912 | — | $0 | 8,912 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | A Award | 2018-06-07 | 2018-06-11 | 3,081 | — | $0 | 8,895 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2018-06-01 | 2018-06-05 | 3,229 | — | $0 | 3,229 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2018-06-01 | 2018-06-05 | 2,188 | — | $0 | 2,188 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2018-06-01 | 2018-06-05 | 1,801 | — | $0 | 8,113 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | D To issuer | 2018-06-01 | 2018-06-05 | 2,188 | — | $0 | 5,925 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | M Exercise deriv | 2018-05-16 | 2018-05-18 | 10,000 | — | $0 | 20,000 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | M Exercise | 2018-05-16 | 2018-05-18 | 10,000 | $3.32 | $33.2K | 25,814 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | S Sale | 2018-05-16 | 2018-05-18 | 10,000 | $16.00 | $160.0K | 15,814 | SEC↗ |
| APD AIR PRODUCTS & CHEMICALS I | A Award deriv | 2018-03-31 | 2018-04-03 | 208 | $158.18 | $33.0K | 34,936 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2018-03-02 | 2018-03-05 | 10,000 | — | $0 | 10,000 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2018-03-02 | 2018-03-05 | 10,000 | $170.00 | $1.70M | 6,312 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2018-03-02 | 2018-03-05 | 10,000 | $81.54 | $815.4K | 16,312 | SEC↗ |
| APD AIR PRODUCTS & CHEMICALS I | A Award deriv | 2018-01-25 | 2018-01-29 | 863 | $174.00 | $150.2K | 34,727 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2018-01-23 | 2018-01-24 | 10,000 | — | $0 | 0 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2018-01-23 | 2018-01-24 | 10,000 | $165.00 | $1.65M | 6,217 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2018-01-23 | 2018-01-24 | 10,000 | $59.55 | $595.5K | 16,217 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2018-01-22 | 2018-01-24 | 10,000 | — | $0 | 10,000 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2018-01-22 | 2018-01-24 | 10,000 | $160.00 | $1.60M | 6,217 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2018-01-22 | 2018-01-24 | 10,000 | $59.55 | $595.5K | 16,217 | SEC↗ |
| APD AIR PRODUCTS & CHEMICALS I | A Award deriv | 2017-12-31 | 2018-01-02 | 200 | $163.67 | $32.8K | 33,864 | SEC↗ |
| APD AIR PRODUCTS & CHEMICALS I | A Award deriv | 2017-09-30 | 2017-10-02 | 215 | $151.32 | $32.6K | 33,664 | SEC↗ |
| APD AIR PRODUCTS & CHEMICALS I | A Award deriv | 2017-06-30 | 2017-07-05 | 223 | $144.84 | $32.4K | 33,449 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | A Award deriv | 2017-06-13 | 2017-06-15 | 16,236 | — | $0 | 16,236 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | A Award | 2017-06-13 | 2017-06-15 | 5,814 | — | $0 | 5,814 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | A Award | 2017-06-13 | 2017-06-16 | 5,814 | — | $0 | 15,814 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2017-06-01 | 2017-06-05 | 5,295 | — | $0 | 5,295 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2017-06-01 | 2017-06-05 | 2,188 | — | $0 | 6,217 | SEC↗ |
| APD AIR PRODUCTS & CHEMICALS I | A Award deriv | 2017-03-31 | 2017-04-04 | 203 | $136.78 | $27.7K | 33,225 | SEC↗ |
| APD AIR PRODUCTS & CHEMICALS I | A Award deriv | 2017-01-26 | 2017-01-27 | 807 | $148.81 | $120.1K | 33,023 | SEC↗ |
| APD AIR PRODUCTS & CHEMICALS I | A Award deriv | 2016-12-31 | 2017-01-04 | 190 | $145.12 | $27.5K | 32,216 | SEC↗ |
| APD AIR PRODUCTS & CHEMICALS I | A Award deriv | 2016-09-30 | 2016-09-30 | 183 | $149.78 | $27.4K | 32,026 | SEC↗ |
| APD AIR PRODUCTS & CHEMICALS I | A Award deriv | 2016-06-30 | 2016-07-05 | 199 | $136.55 | $27.2K | 31,843 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | A Award deriv | 2016-06-09 | 2016-06-13 | 20,000 | — | $0 | 20,000 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2016-06-01 | 2016-06-03 | 7,073 | — | $0 | 7,073 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2016-06-01 | 2016-06-03 | 2,941 | $0.01 | $29 | 4,029 | SEC↗ |
| APD AIR PRODUCTS & CHEMICALS I | A Award deriv | 2016-03-31 | 2016-04-25 | 170 | $145.03 | $24.7K | 31,644 | SEC↗ |
| APD AIR PRODUCTS & CHEMICALS I | A Award deriv | 2016-03-31 | 2016-03-31 | 343 | $145.03 | $49.7K | 31,816 | SEC↗ |
| APD AIR PRODUCTS & CHEMICALS I | A Award deriv | 2016-01-28 | 2016-01-29 | 1,009 | $119.01 | $120.1K | 31,474 | SEC↗ |
| APD AIR PRODUCTS & CHEMICALS I | A Award deriv | 2015-12-31 | 2016-01-05 | 401 | $133.20 | $53.4K | 30,465 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2015-11-18 | 2015-11-20 | 12,500 | — | $0 | 0 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2015-11-18 | 2015-11-20 | 12,500 | $130.15 | $1.63M | 1,088 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2015-11-18 | 2015-11-20 | 12,500 | $57.27 | $715.9K | 13,588 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | P Buy | 2015-11-10 | 2015-11-10 | 10,000 | $10.27 | $102.7K | 10,000 | SEC↗ |
| APD AIR PRODUCTS & CHEMICALS I | A Award deriv | 2015-09-30 | 2015-09-30 | 439 | $125.25 | $55.0K | 30,064 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2015-08-03 | 2015-08-05 | 12,500 | — | $0 | 12,500 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2015-08-03 | 2015-08-05 | 100 | $138.98 | $13.9K | 1,088 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2015-08-03 | 2015-08-05 | 2,700 | $138.22 | $373.2K | 1,188 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2015-08-03 | 2015-08-05 | 6,500 | $137.26 | $892.2K | 3,888 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2015-08-03 | 2015-08-05 | 3,200 | $136.49 | $436.8K | 10,388 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2015-08-03 | 2015-08-05 | 12,500 | $57.27 | $715.9K | 13,588 | SEC↗ |
| APD AIR PRODUCTS & CHEMICALS I | A Award deriv | 2015-06-30 | 2015-06-30 | 388 | $142.08 | $55.2K | 29,625 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | A Award deriv | 2015-06-10 | 2015-06-12 | 20,000 | — | $0 | 20,000 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2015-06-01 | 2015-06-03 | 7,500 | — | $0 | 0 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2015-06-01 | 2015-06-03 | 20,000 | — | $0 | 20,000 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2015-06-01 | 2015-06-03 | 5,000 | — | $0 | 25,000 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2015-06-01 | 2015-06-03 | 9,020 | $127.53 | $1.15M | 1,088 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2015-06-01 | 2015-06-03 | 3,480 | $126.78 | $441.2K | 10,108 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2015-06-01 | 2015-06-03 | 7,500 | $53.85 | $403.9K | 13,588 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2015-06-01 | 2015-06-03 | 5,000 | $57.27 | $286.4K | 6,088 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2015-04-06 | 2015-04-08 | 12,500 | — | $0 | 7,500 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2015-04-06 | 2015-04-08 | 400 | $119.78 | $47.9K | 1,088 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2015-04-06 | 2015-04-08 | 3,900 | $118.97 | $464.0K | 1,488 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2015-04-06 | 2015-04-08 | 6,000 | $118.32 | $709.9K | 5,388 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2015-04-06 | 2015-04-08 | 2,200 | $117.14 | $257.7K | 11,388 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2015-04-06 | 2015-04-08 | 12,500 | $53.85 | $673.1K | 13,588 | SEC↗ |
| APD AIR PRODUCTS & CHEMICALS I | A Award deriv | 2015-03-31 | 2015-03-31 | 369 | $152.75 | $56.3K | 29,237 | SEC↗ |
| APD AIR PRODUCTS & CHEMICALS I | A Award deriv | 2015-01-22 | 2015-01-23 | 832 | $144.32 | $120.1K | 28,868 | SEC↗ |
| APD AIR PRODUCTS & CHEMICALS I | A Award deriv | 2014-12-31 | 2015-01-05 | 353 | $147.57 | $52.1K | 28,036 | SEC↗ |
| APD AIR PRODUCTS & CHEMICALS I | A Award deriv | 2014-09-30 | 2014-09-30 | 414 | $134.77 | $55.7K | 27,683 | SEC↗ |
| APD AIR PRODUCTS & CHEMICALS I | A Award deriv | 2014-06-30 | 2014-06-30 | 415 | $128.83 | $53.4K | 27,270 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | A Award deriv | 2014-06-12 | 2014-06-16 | 15,000 | — | $0 | 15,000 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2014-06-01 | 2014-06-03 | 20,000 | — | $0 | 20,000 | SEC↗ |
| APD AIR PRODUCTS & CHEMICALS I | A Award deriv | 2014-03-31 | 2014-04-01 | 445 | $118.44 | $52.7K | 26,855 | SEC↗ |
| APD AIR PRODUCTS & CHEMICALS I | A Award deriv | 2014-01-23 | 2014-01-24 | 1,081 | $111.01 | $120.0K | 26,410 | SEC↗ |
| APD AIR PRODUCTS & CHEMICALS I | A Award deriv | 2013-12-31 | 2014-01-03 | 452 | $113.43 | $51.3K | 25,329 | SEC↗ |
| APD AIR PRODUCTS & CHEMICALS I | A Award deriv | 2013-09-30 | 2013-09-30 | 465 | $109.78 | $51.1K | 24,876 | SEC↗ |
| APD AIR PRODUCTS & CHEMICALS I | A Award deriv | 2013-06-30 | 2013-07-01 | 445 | $96.13 | $42.8K | 24,411 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | A Award deriv | 2013-06-13 | 2013-06-17 | 15,000 | — | $0 | 15,000 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2013-06-01 | 2013-06-04 | 20,000 | — | $0 | 20,000 | SEC↗ |
| APD AIR PRODUCTS & CHEMICALS I | A Award deriv | 2013-03-29 | 2013-04-01 | 486 | $86.28 | $41.9K | 23,966 | SEC↗ |
| APD AIR PRODUCTS & CHEMICALS I | A Award deriv | 2013-01-24 | 2013-01-25 | 1,361 | $88.23 | $120.1K | 23,480 | SEC↗ |
| APD AIR PRODUCTS & CHEMICALS I | A Award deriv | 2012-12-31 | 2013-01-02 | 483 | $84.80 | $41.0K | 22,119 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | P Buy | 2012-11-07 | 2012-11-08 | 1,000 | $45.50 | $45.5K | 1,000 | SEC↗ |
| APD AIR PRODUCTS & CHEMICALS I | A Award deriv | 2012-09-28 | 2012-10-01 | 496 | $83.18 | $41.3K | 21,636 | SEC↗ |
| APD AIR PRODUCTS & CHEMICALS I | A Award deriv | 2012-06-29 | 2012-07-02 | 509 | $76.56 | $39.0K | 21,140 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | A Award deriv | 2012-06-13 | 2012-06-15 | 15,000 | — | $0 | 15,000 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2012-06-01 | 2012-06-01 | 20,000 | — | $0 | 20,000 | SEC↗ |
| APD AIR PRODUCTS & CHEMICALS I | A Award deriv | 2012-03-30 | 2012-03-30 | 458 | $90.49 | $41.4K | 20,631 | SEC↗ |
| APD AIR PRODUCTS & CHEMICALS I | A Award deriv | 2012-01-26 | 2012-01-27 | 1,362 | $88.16 | $120.1K | 20,174 | SEC↗ |
| APD AIR PRODUCTS & CHEMICALS I | A Award deriv | 2011-12-31 | 2012-01-04 | 408 | $84.98 | $34.7K | 18,812 | SEC↗ |